SURGERY PARTNERS INC
SGRYNASDAQ🏆 #1524 by market capEarnings Nov 9 · PreUS Equity
$1,017.75▼ $65.14 (−6.40%)
Simulated price1h—
24h▼ 6.4%
7d—
14d—
30d—
1y—
🏦Market Cap
$1.96B
Small Cap
📈Revenue Growth (YoY)
-20.5%
Declining
📊Gross Margin
25.2%
Moderate
💵FCF Margin
8.4%
Moderate
⚖️P/S Ratio
0.8x
Cheap
Otter Score
47
Weak
No chart data available for SGRY.
Trading Snapshot
- Day Range
- $1,005.96 – $1,028.13
- 52-Week Range
- $11.41 – $24.10
- Volume
- $5.66B
- Avg Volume
- $5.83B
- Shares Outstanding
- 130.8M
- Next Earnings
- Sep 12, 2026
Fundamentals Snapshot
- Annual Revenue
- $2.42B
- Last Q Revenue
- $562M
- P/E Ratio
- —
- P/S Ratio
- 0.8x
- EPS (TTM)
- $-0.61
- Dividend Yield
- —
Why Investors Own SGRY
- ✓High-growth profile — revenue up +0.4% YoY with expanding US Equity exposure.
- ✓Healthy economics — 48% gross margin and 17% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$2.42B▼ −3.1% YoY
Gross Margin (TTM)
47.6%▲ +3.9% YoY
Operating Income (TTM)
$336M▼ −3.1% YoY
Free Cash Flow (TTM)
$419M▼ −3.1% YoY
About SURGERY PARTNERS INC
A company profile for SURGERY PARTNERS INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
47/100
Analyst Price Target
ⓘAverage Target
$1,333.38
▲ +31.0% Upside
High Target$1,484.77
Low Target$1,104.74
Based on 21 analysts
Latest News & Updates
🚀
CNBC·2h ago
SURGERY PARTNERS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Bloomberg·5h ago
Analysts lift SGRY price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Bloomberg·1d ago
SURGERY PARTNERS INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.